About Hospital Quiron de Madrid; Servicio de Oncologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Quiron de Madrid; Servicio de Oncologia
During the past decade, Hospital Quiron de Madrid; Servicio de Oncologia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2014-06-25
2018-05-29
Completed
444
A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer
2015-02-17
2017-08-02
Completed
151
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
2017-09-22
2024-04-27
Recruiting
1,000
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
2017-10-25
2022-04-07
Completed
619
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
2018-07-10
2024-06-09
Active, not recruiting
790
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
2019-02-07
2026-12-19
Recruiting
3,400
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Quiron de Madrid; Servicio de Oncologia"
#1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hospital Quiron de Madrid; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital Quiron de Madrid; Servicio de Oncologia" are
"Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Cancer of Unknown Primary Site" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hospital Quiron de Madrid; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Quiron de Madrid; Servicio de Oncologia
Most popular intervention types in "Hospital Quiron de Madrid; Servicio de Oncologia" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (5 trials), "Carboplatin" (3 trials), "Trastuzumab Emtansine" (3 trials), "Alectinib" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Quiron de Madrid; Servicio de Oncologia
The vast majority of trials in "Hospital Quiron de Madrid; Servicio de Oncologia" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Quiron de Madrid; Servicio de Oncologia
Currently, there are NaN active trials in "Hospital Quiron de Madrid; Servicio de Oncologia".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hospital Quiron de Madrid; Servicio de Oncologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Quiron de Madrid; Servicio de Oncologia, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".